Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic disorders and inflammation are associated with familial combined hyperlipemia.

Clinica chimica acta; international journal of clinical chemistry - 1 Mar 2019

Díaz-Ruiz María, Martínez-Triguero María L, López-Ruiz Antonio, Fernández-de la Cruz Francis, Bañuls Celia, Hernández-Mijares Antonio

Abstract excerpt

BACKGROUND: Familial Combined Hyperlipidemia (FCH) is related to different metabolic disorders. The objective of this study was to evaluate the presence of alterations of hydrocarbonated metabolism and lipid profile together with inflammatory and adhesion molecules in subjects with FCH compared to controls. METHODS: 75 HFC patients and 75 healthy individuals were studied. Glucose, insulin, HOMA-IR index and lipid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Hyperlipidemia, Familial Combined

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Phenotype

Source

Identifiers

PMID: 30201373
DOI: 10.1016/j.cca.2018.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic disorders and inflammation are associated with familial combined hyperlipemia.PMID 30201373Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.Semantic proximity Read ↗

Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A reviewSemantic proximity Read ↗

Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.Semantic proximity Read ↗

Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors.Semantic proximity Read ↗

Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.Semantic proximity Read ↗

Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.Semantic proximity Read ↗

Familial Hypertriglyceridemia: An Entity with Distinguishable Features from other Causes of HypertriglyceridemiaSemantic proximity Read ↗

Genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.Semantic proximity Read ↗

Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.Semantic proximity Read ↗

[Familial combined hyperlipidemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.